These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 13751977)

  • 41. AKR mouse leukemic cells in tissue culture. II. Immunologic studies on the AKR 87 cell line.
    Duś D; Harlozińska A; Skriabin A; Richter R
    Arch Immunol Ther Exp (Warsz); 1976; 24(5):727-40. PubMed ID: 187141
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Elevated ribonuclease activity in the thymus and white blood cells of genetically cancer prone mice.
    Drake WP; Pokorney DR; Chipman S; Levy CC; Mardiney MR
    J Exp Med; 1975 Apr; 141(4):918-23. PubMed ID: 1092792
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Leukemogenesis stimulation by X rays in AKR and AKR-T1 Ald mice].
    Léonard A; Deknudt G; Linden G
    C R Seances Soc Biol Fil; 1973; 167(6):1055-7. PubMed ID: 4803157
    [No Abstract]   [Full Text] [Related]  

  • 44. Studies on leukemogenesis by cell-free filtrates of AKR mouse leukemia.
    OKADA K; MIYOSHI I; KAWAMURA N; SATO M
    Nihon Ketsueki Gakkai Zasshi; 1962 Feb; 25():1-11. PubMed ID: 14481486
    [No Abstract]   [Full Text] [Related]  

  • 45. CHROMOSOME PATTERNS IN THE AKR MOUSE: SPONTANEOUS LEUKEMIA, ASCITES TRANSFERS, AND TISSUE CULTURE CELL LINES.
    CAILLEAU R; MUNRO MM
    J Natl Cancer Inst; 1964 Nov; 33():813-24. PubMed ID: 14231154
    [No Abstract]   [Full Text] [Related]  

  • 46. Urethan and x-ray effects on mice of a tumor-resistant strain, X-Gf.
    Goldfeder A
    Cancer Res; 1972 Dec; 32(12):2771-7. PubMed ID: 4345404
    [No Abstract]   [Full Text] [Related]  

  • 47. Prevention of spontaneous leukemia in AKR mice by passive immunization and type specificity of this protection.
    Fish DC; Gilden RV; Bare RM; Trimmer RM; Huebner RJ
    J Natl Cancer Inst; 1979 Apr; 62(4):943-5. PubMed ID: 219284
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term carcinogenicity of cyclophosphamide in two mouse strains with different spontaneous leukemia incidence.
    Petru E; Berger MR; Schmähl D
    Cancer Lett; 1989 Mar; 44(3):221-6. PubMed ID: 2924289
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunoadjuvant treatment of primary grafted and spontaneous AKR-leukemia. I. Treatment efficiency correlated to autoimmune reactivity.
    Olsson L; Ebbesen P
    J Immunol; 1979 Mar; 122(3):772-80. PubMed ID: 376705
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alloimmunization: induction of antileukemic reactivity without modification of anti-host reactivity in H-2-compatible mice.
    Truitt RL; Bortin MM; Rimm AA
    Transplant Proc; 1980 Mar; 12(1):143-6. PubMed ID: 6966095
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Repetitive administration of BCG in prevention and treatment of spontaneous leukemia of AKR mice.
    Ungaro PC; Drake WP; Mardiney MR
    J Natl Cancer Inst; 1973 Jan; 50(1):125-8. PubMed ID: 4692859
    [No Abstract]   [Full Text] [Related]  

  • 52. [Immunologic status and frequency of leukemia in mouse strains AKR and CC57BR following chronic immunization with ADPT vaccine].
    Babinkov VI
    Patol Fiziol Eksp Ter; 1976; (3):49-52. PubMed ID: 1012762
    [No Abstract]   [Full Text] [Related]  

  • 53. Active immunotherapy of AkR mice spontaneous leukemia.
    Mathé G; Halle-Pannenko O; Bourut C
    Rev Eur Etud Clin Biol; 1972 Dec; 17(10):997-1000. PubMed ID: 4660002
    [No Abstract]   [Full Text] [Related]  

  • 54. Pathogenetic mechanisms in immune polioencephalomyelitis: induction of disease in immunosuppressed mice.
    Duffey PS; Martinez D; Abrams GD; Murphy WH
    J Immunol; 1976 Feb; 116(2):475-81. PubMed ID: 1249421
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Triggering of leukemia in thymectomized AKR mice by a membrane fraction of thymic stroma.
    Fournier M; Potworowski EF
    Thymus; 1983 Mar; 5(2):89-94. PubMed ID: 6602405
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Variability in AKR mouse leukemia mortality.
    Kohn RR; Novak D
    J Natl Cancer Inst; 1973 Aug; 51(2):683-5. PubMed ID: 4765381
    [No Abstract]   [Full Text] [Related]  

  • 57. [Oncological characteristics of AKR/JY mice].
    Khar'kovskaia NA; Khrustalev SA
    Eksp Onkol; 1984; 6(4):62-6. PubMed ID: 6548693
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype.
    Green WR
    J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A quantitative study of the leukemogenic action of whole-body x-irradiation and urethane. II. In newborn C57BL mice.
    Chen L; Berenblum I
    Isr J Med Sci; 1968; 4(6):1164-8. PubMed ID: 5756643
    [No Abstract]   [Full Text] [Related]  

  • 60. [Presumable role of milk of AKR mice in the transmission of Gross leukemia].
    Harlozińska A; Salwa J
    Patol Pol; 1973; 24(2):281-8. PubMed ID: 4726768
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.